TearScience explained

TearScience is an American company founded in 2005 that develops, manufactures and markets ophthalmic medical devices aiding in the identification and treatment of meibomian gland dysfunction, which can lead to dry eye disease,[1] which is a condition that affect as many as 25 million Americans. The company's Lipiflow System was FDA cleared in June 2011 for treating meibomian gland dysfunction[2] and is currently installed in over 250 locations across the globe. The company is headquartered in Morrisville, North Carolina.

Products

LipiView Ocular Surface uses interferometry to measure the thickness of the tear film oily lipid layer.[3] LipiFlow Thermal Pulsation System uses heat and pressure to unblock obstructed meibomian glands[4] to reduce dry eye symptoms.[5]

External links

Notes and References

  1. Web site: Hawaiian Eye & Retina 2021 Meeting - Home. 2020-07-27. www.healio.com. en.
  2. Lane SS, etal . A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. . Cornea . 2012 . 31 . 4 . 396–404 . 10.1097/ico.0b013e318239aaea . 22222996.
  3. Correlation between quantitative measurements of tear film lipid layer thickness andmeibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls. . Eom Y, Lee JS, Kang SY, Kim HM, Song JS . American Journal of Ophthalmology . June 2013 . 155 . 6 . 1104–1110 . 10.1016/j.ajo.2013.01.008 . Epub 2013 Mar 7 . 23465270.
  4. Korb DR, Blackie CA . Restoration of meibomian gland functionality with novel thermodynamic treatment device-a case report. . Cornea . August 2010 . 29 . 8. 930–933 . 10.1097/ICO.0b013e3181ca36d6 . 20531168.
  5. Greiner JV. . A single LipiFlow® Thermal Pulsation System treatment improves meibomian glandfunction and reduces dry eye symptoms for 9 months. . Current Eye Research . April 2012 . 37 . 4 . 272–278 . 10.3109/02713683.2011.631721 . 22324772.